Adaptive Biotechnologies share price logo

Adaptive Biotechnologies

NASDAQ: ADPT

Mid Cap

$24.32

-0.60

(-2.39%)

as on

Adaptive Biotechnologies Stock Performance

as on September 2, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $24.20
    $24.97
    downward going graph

    0.49%

    Downside

    2.67%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $12.00
    $26.87
    downward going graph

    50.66%

    Downside

    10.49%

    Upside

    downward going graph

Adaptive Biotechnologies share price movements today

Previous Close
$24.92
Open
$24.87
Volume
1.3M
Market Cap
$4.0B
Day's Low - High
$24.20 - $24.97
52 Week Low - High
$12.00 - $26.87

Adaptive Biotechnologies Historical Returns

1 Month Return
+ 11.61 %
3 Month Return
+ 66.27 %
1 Year Return
+ 91.12 %
3 Year Return
+ 272.08 %
5 Year Return
-30.64 %

Adaptive Biotechnologies Stock Fundamentals & Key Indicators

Check Adaptive Biotechnologies market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.0B

EPS (TTM)

-0.4074

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-60.04

Industry PE ratio

41.77

PEG Ratio

-1.191991792549242

EBITDA

-16.0M

Revenue (TTM)

308.1M

Profit Margin

75.44%

Return On Equity TTM

-32.64%

Adaptive Biotechnologies Stock Valuation

Track how Adaptive Biotechnologies P/E has moved over time to understand its valuation trends.

Adaptive Biotechnologies in the last 5 years

  • Overview

  • Trends

Lowest (-41.64x)

December 31, 2025

Today (-41.64x)

December 31, 2025

Industry (41.77x)

December 31, 2025

Highest (-3.14x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -41.64x

Adaptive Biotechnologies vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adaptive Biotechnologies with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$4.0B-30.64%-60.0475.44%NA
BUY$47.0B175.49%-228.5165.30%NA
BUY$232.3B12.11%3240.37%0.3%
BUY$43.7B-17.63%38.6262.45%NA
BUY$151.8B-33.34%38.2258.51%0.67%

Stock Returns calculator for Adaptive Biotechnologies Stock including INR - Dollar returns

The Adaptive Biotechnologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Adaptive Biotechnologies investment value today

Current value as on today

₹1,99,072

Returns

₹99,072

(+99.07%)

Returns from Adaptive Biotechnologies Stock

₹84,522 (+84.52%)

Dollar Impact

₹14,550 (+14.55%)

Analyst Recommendation on Adaptive Biotechnologies Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Adaptive Biotechnologies. Average target price of $25.07

Adaptive Biotechnologies Share Price Target

Get share price movements and forecasts by analysts on Adaptive Biotechnologies.

What analysts predicted

2.99%UPSIDE

Target Price

$25.07

Current Price

$24.32

Analyzed by

8 Analysts

Target

$25.07

Adaptive Biotechnologies target price $25.07, a slight upside of 2.99% compared to current price of $24.32. According to 8 analysts rating.

Indian Investors' Interest in Adaptive Biotechnologies Stock

Search interest for Adaptive Biotechnologies Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Adaptive Biotechnologies Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
41
43
46
47
52
58
93
71
70
71
Gross Profit
23
23
29
29
35
40
75
53
52
50
Operating Income
-48
-47
-32
-33
-29
-25
10
-12
-19
-15
EBITDA
-39
-38
-24
-26
-29
-18
16
-6
-14
-12
Interest Expense
2
2
2
2
2
2
2
2
2
2
Depreciation
5
5
4
4
3
4
4
4
3
3
Income Before Tax
-47
-46
-32
-33
-29
-25
9
-13
-20
-39
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-47
-46
-32
-33
-29
-25
9
-13
-20
-39
Net Profit Margin
56.89%
55.27%
64.11%
61.98%
67.62%
69.43%
80.68%
74.58%
73.60%
71.23%

Adaptive Biotechnologies Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
38
55
85
98
154
185
170
178
276
Gross Profit
22
35
62
75
105
127
94
106
205
Operating Income
-44
-49
-78
-152
-208
-200
-227
-162
-57
EBITDA
-37
-43
-70
-144
-193
-175
-189
-128
-29
Interest Expense
-
-
-
-
-
4
13
11
11
Depreciation
5
6
7
8
13
20
22
19
17
Income Before Tax
-42
-46
-68
-146
-207
-200
-225
-159
-59
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-42
-46
-68
-146
-207
-200
-225
-159
-59
Net Profit Margin
59.22%
64.67%
73.82%
77.10%
68.06%
68.75%
55.63%
59.72%
74.24%

Adaptive Biotechnologies Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-47
-46
-32
-33
-29
-25
9
-13
-20
-39
Operating Cash Flow
-38
-17
-27
-12
-28
-12
-7
2
-9
-6
Investing Cash Flow
44
5
5
22
25
3
17
-8
9
-43
Financing Cash Flow
0
0
0
0
5
1
1
21
7
142
Change in Cash
6
-11
-21
9
2
-7
11
15
7
92

Adaptive Biotechnologies Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-42
-46
-68
-146
-207
-200
-225
-159
-59
Operating Cash Flow
-34
-32
205
-149
-192
-183
-156
-95
-45
Investing Cash Flow
36
0
-481
-117
181
2
129
77
37
Financing Cash Flow
50
1
319
293
27
132
2
0
30
Change in Cash
51
-30
43
26
15
-49
-24
-17
22

Mutual Funds that own Adaptive Biotechnologies Stock

Check out the Mutual Funds with significant holdings in Adaptive Biotechnologies.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
5.373833%
8576414
IVY FUNDS
1.332423%
2126493
Fidelity Salem Street Trust
1.201681%
1917833
ALGER FUNDS
1.08054%
1724497
LORD ABBETT DEVELOPING GROWTH FUND, INC.
1.063782%
1697752

Global Institutional Holdings in Adaptive Biotechnologies

Funds
Holdings
Andreas Halvorsen
18.79%
Vanguard
6.58%
iShares
4.82%
Richard Driehaus
1.58%
Cathie Wood
1.31%

Adaptive Biotechnologies News & Key Events

  • img

    Today's Timeline - 01 September

    Wed, 01:35 AM

    -

    Adaptive Biotechnologies to participate in Morgan Stanley Global Healthcare Conference on September 15, 2026.

Insights on Adaptive Biotechnologies

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 70.87M → 71.55M (in $), with an average increase of 1.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ADPT stock has moved up by 63.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 415.0% return, outperforming this stock by 149.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Natera, Inc. Common Stock has given 91.4% return, outperforming this stock by 2.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 9.54M → -39.78M (in $), with an average decrease of 129.5% per quarter

About Adaptive Biotechnologies

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
OrganisationAdaptive Biotechnologies
Headquarters1165 Eastlake Avenue East, Seattle, WA, United States, 98109
IndustryDiagnostics & Research
CEOMr. Chad M. Robins M.B.A.
E-voting on sharesClick here to vote

Key Management of Adaptive Biotechnologies

Name

Title

Mr. Francis T. Lo

Chief People Officer

Dr. Sharon Benzeno Ph.D.

Chief Commercial Officer of Immune Medicine

Mr. Chad M. Robins M.B.A.

Co-Founder, CEO & Chairman

Ms. Julie Rubinstein

President & COO

Ms. Susan Bobulsky

Chief Commercial Officer of MRD

Mr. Christopher Carlson Ph.D.

Founder

Ms. Karina Calzadilla

VP of Investor Relations and FP&A

Ms. Clarice McCauley

Head of Legal, Corporate Secretary, VP & Chief Compliance Officer

Mr. Kyle Piskel

VP, CFO & Principal Accounting Officer

Ms. Mary Pat Lancelotta

Senior Vice President of MRD BioPharma

FAQs

What is Adaptive Biotechnologies share price today?

Adaptive Biotechnologies share price today is $24.32 as on at the close of the market. Adaptive Biotechnologies share today touched a day high of $24.97 and a low of $24.20.

What is the 52 week high and 52 week low for Adaptive Biotechnologies share?

Adaptive Biotechnologies share touched a 52 week high of $26.87 on and a 52 week low of $12.00 on . Adaptive Biotechnologies stock price today i.e. is closed at $24.32,which is 9.49% down from its 52 week high and 102.67% up from its 52 week low.

What is Adaptive Biotechnologies's market capitalisation today?

Adaptive Biotechnologies market capitalisation is $0.00T as on .

How to invest in Adaptive Biotechnologies Stock (ADPT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Adaptive Biotechnologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adaptive Biotechnologies Shares that will get you 0.0617 shares as per Adaptive Biotechnologies share price of $24.32 per share as on September 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Adaptive Biotechnologies Stock (ADPT) from India?

Indian investors can start investing in Adaptive Biotechnologies (ADPT) shares with as little as ₹94.94 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Adaptive Biotechnologies stock (as per the Rupee-Dollar exchange rate as on ). Based on Adaptive Biotechnologies share’s latest price of $24.32 as on September 2, 2026 at 1:29 am IST, you will get 0.4112 shares of Adaptive Biotechnologies. Learn more about fractional shares .

What are the returns that Adaptive Biotechnologies has given to Indian investors in the last 5 years?

Adaptive Biotechnologies stock has given -30.64% share price returns and 30.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?